JAMES INVESTMENT RESEARCH INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
JAMES INVESTMENT RESEARCH INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$278,000
-48.0%
36,270
-10.0%
0.02%
-42.9%
Q1 2019$535,000
+21.3%
40,290
+42.4%
0.04%
+29.6%
Q4 2018$441,000
-82.2%
28,290
-77.6%
0.03%
-73.5%
Q3 2018$2,478,000126,1300.10%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders